AU2019432306B2 - Tableted cannabinoid chewing gum with layered structure - Google Patents

Tableted cannabinoid chewing gum with layered structure Download PDF

Info

Publication number
AU2019432306B2
AU2019432306B2 AU2019432306A AU2019432306A AU2019432306B2 AU 2019432306 B2 AU2019432306 B2 AU 2019432306B2 AU 2019432306 A AU2019432306 A AU 2019432306A AU 2019432306 A AU2019432306 A AU 2019432306A AU 2019432306 B2 AU2019432306 B2 AU 2019432306B2
Authority
AU
Australia
Prior art keywords
chewing gum
tableted
layer
particles
cannabinoids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2019432306A
Other languages
English (en)
Other versions
AU2019432306A1 (en
Inventor
Dorte Schackinger BOESEN
Heidi Ziegler Bruun
Ane Eriksen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nordiccan AS
Original Assignee
Nordiccan AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA3035400A external-priority patent/CA3035400C/en
Priority claimed from US16/289,770 external-priority patent/US10799450B2/en
Application filed by Nordiccan AS filed Critical Nordiccan AS
Publication of AU2019432306A1 publication Critical patent/AU2019432306A1/en
Application granted granted Critical
Publication of AU2019432306B2 publication Critical patent/AU2019432306B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/068—Chewing gum characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/18—Chewing gum characterised by shape, structure or physical form, e.g. aerated products
    • A23G4/20—Composite products, e.g. centre-filled, multi-layer, laminated
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Physiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Confectionery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2019432306A 2019-03-01 2019-10-10 Tableted cannabinoid chewing gum with layered structure Active AU2019432306B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16/289,770 2019-03-01
CA3035400A CA3035400C (en) 2019-03-01 2019-03-01 Tableted cannabinoid chewing gum with layered structure
US16/289,770 US10799450B2 (en) 2019-03-01 2019-03-01 Tableted cannabinoid chewing gum with layered structure
CA3,035,400 2019-03-01
PCT/DK2019/050308 WO2020177819A1 (en) 2019-03-01 2019-10-10 Tableted cannabinoid chewing gum with layered structure

Publications (2)

Publication Number Publication Date
AU2019432306A1 AU2019432306A1 (en) 2021-07-08
AU2019432306B2 true AU2019432306B2 (en) 2023-01-05

Family

ID=68617969

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2019432306A Active AU2019432306B2 (en) 2019-03-01 2019-10-10 Tableted cannabinoid chewing gum with layered structure

Country Status (9)

Country Link
EP (2) EP3876744B1 (https=)
JP (1) JP7601779B2 (https=)
CN (1) CN113423279A (https=)
AU (1) AU2019432306B2 (https=)
BR (1) BR112021012489A2 (https=)
ES (1) ES2970150T3 (https=)
MX (1) MX2021008938A (https=)
WO (1) WO2020177819A1 (https=)
ZA (1) ZA202104509B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12383591B2 (en) * 2019-11-12 2025-08-12 London Pharmaceuticals And Research Corporation Chewing gum containing synergistic medicinal compounds
WO2024227046A2 (en) * 2023-04-28 2024-10-31 Whelpley Gordon Brittain Iii Spray application of water-soluble actives to drinking vessels and other objects

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009120080A1 (en) * 2008-03-26 2009-10-01 Mareda Holding Bv Chewing gum compositions comprising cannabinoids
WO2017059859A1 (en) * 2015-10-07 2017-04-13 Medcan Pharma A/S Medical chewing gum comprising cannabinoid
US20170265494A1 (en) * 2017-06-05 2017-09-21 International Consolidated Companies, Inc. Chewing gum including nanozome encapsulated cannabidiol
WO2017202424A1 (en) * 2016-05-27 2017-11-30 Medcan Pharma A/S Powdered composition comprising a complex between a cannabinoid and a basic ion exchange resin

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU71919A1 (https=) * 1975-02-26 1977-01-06
GB0216413D0 (en) * 2002-07-15 2002-08-21 Nestle Sa Tabletted chewing gum sweet
EP1449525A1 (en) * 2003-02-20 2004-08-25 Cross Chem Llc chewing gum in the form of multi-layer tablets
EP1554935A1 (en) * 2004-01-19 2005-07-20 Gumlink A/S Layered chewing gum tablet
DK200401195A (da) * 2004-08-06 2004-08-06 Gumlink As Layered chewing gum tablet
WO2006063189A2 (en) * 2004-12-10 2006-06-15 Novartis Ag Multi-layered chewing gum tablet with quick disintegration layer
DK2229156T3 (en) * 2007-12-20 2017-02-06 Fertin Pharma As CHEW GUM TABLE AND PROCEDURE FOR DOSING PHARMACEUTICAL ACTIVE INGREDIENTS IN SUCH CHEW GUM TABLE
JP2010252816A (ja) * 2010-08-23 2010-11-11 Gumlink As 圧縮チューインガムタブレット
US20140083878A1 (en) * 2012-09-21 2014-03-27 Mylan Inc. Transdermal drug delivery device
HK1247084A1 (zh) * 2015-02-02 2018-09-21 APIRx Pharmaceuticals, LLC 大麻素和糖醇复合物，制备和使用的方法
WO2018102296A1 (en) * 2016-11-29 2018-06-07 Axim Biotechnologies, Inc. Chewing gum composition comprising cannabinoids and gabapentin

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009120080A1 (en) * 2008-03-26 2009-10-01 Mareda Holding Bv Chewing gum compositions comprising cannabinoids
WO2017059859A1 (en) * 2015-10-07 2017-04-13 Medcan Pharma A/S Medical chewing gum comprising cannabinoid
WO2017202424A1 (en) * 2016-05-27 2017-11-30 Medcan Pharma A/S Powdered composition comprising a complex between a cannabinoid and a basic ion exchange resin
US20170265494A1 (en) * 2017-06-05 2017-09-21 International Consolidated Companies, Inc. Chewing gum including nanozome encapsulated cannabidiol

Also Published As

Publication number Publication date
ZA202104509B (en) 2023-12-20
EP3876744A1 (en) 2021-09-15
EP4306105A3 (en) 2024-04-10
JP7601779B2 (ja) 2024-12-17
EP3876744B1 (en) 2023-12-06
EP4306105A2 (en) 2024-01-17
JP2022521711A (ja) 2022-04-12
BR112021012489A2 (pt) 2021-10-26
EP3876744C0 (en) 2023-12-06
MX2021008938A (es) 2021-08-24
AU2019432306A1 (en) 2021-07-08
WO2020177819A1 (en) 2020-09-10
ES2970150T3 (es) 2024-05-27
CN113423279A (zh) 2021-09-21

Similar Documents

Publication Publication Date Title
US12582602B2 (en) Tableted cannabinoid chewing gum with tableted modules
US10933017B2 (en) Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
US20240065972A1 (en) Cannabinoid chewing gum with sugar alcohols
AU2019432306B2 (en) Tableted cannabinoid chewing gum with layered structure
AU2019432305B2 (en) Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
US11471405B2 (en) Tableted chewing gum with enhanced delivery of cannabinoids
US11253473B2 (en) Method of producing tableted cannabinoid chewing gum
AU2019424012B2 (en) Cannabinoid chewing gum with high intensity sweeteners
AU2019424547B2 (en) Cannabinoid chewing gum with improved release of cannabinoids
AU2019433058B2 (en) Tableted cannabinoid chewing gum with improved release
CA3035400C (en) Tableted cannabinoid chewing gum with layered structure
EP3930473B1 (en) Method of producing tableted cannabinoid chewing gum
CA3035381C (en) Tableted cannabinoid chewing gum with improved release
CA3035409C (en) Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
CA3035390C (en) Tableted chewing gum with enhanced delivery of cannabinoids
AU2019423959B2 (en) Cannabinoid chewing gum with sugar alcohols
CA3035417C (en) Method of producing tableted cannabinoid chewing gum
CA3031499C (en) Cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
US20200276118A1 (en) Tableted cannabinoid chewing gum with improved release
WO2020177822A1 (en) Tableted chewing gum with enhanced delivery of cannabinoids
CA3031519A1 (en) Cannabinoid chewing gum with improved release of cannabinoids

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)